loadpatents
name:-0.028908967971802
name:-0.017050981521606
name:-0.0084471702575684
PIERCE; Glenn Patent Filings

PIERCE; Glenn

Patent Applications and Registrations

Patent applications and USPTO patent grants for PIERCE; Glenn.The latest application filed is for "factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof".

Company Profile
12.28.42
  • PIERCE; Glenn - Rancho Santa Fe CA
  • Pierce; Glenn - Cambridge MA
  • Pierce; Glenn - La Jolla CA
  • Pierce; Glenn - Rancho Sante Fe CA
  • Pierce; Glenn - Thousand Oaks CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Factor Viii-fc Chimeric And Hybrid Polypeptides, And Methods Of Use Thereof
App 20220265780 - DUMONT; Jennifer A. ;   et al.
2022-08-25
Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
Grant 11,286,528 - Jiang , et al. March 29, 2
2022-03-29
Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof
Grant 11,266,720 - Dumont , et al. March 8, 2
2022-03-08
Methods Of Using Fix Polypeptides
App 20220064622 - PIERCE; Glenn ;   et al.
2022-03-03
Methods of using FIX polypeptides
Grant 11,225,650 - Pierce , et al. January 18, 2
2022-01-18
Methods of using FIX polypeptides
Grant 11,193,116 - Pierce , et al. December 7, 2
2021-12-07
Factor Viii Chimeric And Hybrid Polypeptides, And Methods Of Use Thereof
App 20210220476 - DUMONT; Jennifer A. ;   et al.
2021-07-22
Factor Ix Polypeptides And Methods Of Use Thereof
App 20210023185 - PIERCE; Glenn ;   et al.
2021-01-28
Factor IX polypeptides and methods of use thereof
Grant 10,898,554 - Pierce , et al. January 26, 2
2021-01-26
Factor Ix Polypeptides And Methods Of Use Thereof
App 20210008178 - PIERCE; Glenn ;   et al.
2021-01-14
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
Grant 10,881,742 - Dumont , et al. January 5, 2
2021-01-05
Assays To Monitor Bleeding Disorders
App 20200386774 - SOMMER; Jurg ;   et al.
2020-12-10
Assays to monitor bleeding disorders
Grant 10,656,167 - Sommer , et al.
2020-05-19
Factor IX polypeptides and methods of use thereof
Grant 10,568,943 - Pierce , et al. Feb
2020-02-25
Factor IX polypeptides and methods of use thereof
Grant 10,561,714 - Pierce , et al. Feb
2020-02-18
Factor IX polypeptides and methods of use thereof
Grant 10,548,954 - Pierce , et al. Fe
2020-02-04
Factor Viii-fc Chimeric And Hybrid Polypeptides, And Methods Of Use Thereof
App 20190262429 - DUMONT; Jennifer A. ;   et al.
2019-08-29
Methods Of Reducing Immunogenicity Against Factor Viii In Individuals Undergoing Factor Viii Therapy
App 20190241960 - Jiang; Haiyan ;   et al.
2019-08-08
Factor Ix Polypeptides And Methods Of Use Thereof
App 20190192641 - Pierce; Glenn ;   et al.
2019-06-27
Factor Ix Polypeptides And Methods Of Use Thereof
App 20190192640 - Pierce; Glenn ;   et al.
2019-06-27
Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
Grant 10,221,455 - Jiang , et al.
2019-03-05
Factor Viii Chimeric And Hybrid Polypeptides, And Methods Of Use Thereof
App 20180360982 - DUMONT; Jennifer A. ;   et al.
2018-12-20
Factor IX Polypeptides and Methods of Use Thereof
App 20180228879 - PIERCE; Glenn ;   et al.
2018-08-16
Factor IX Polypeptides and Methods of Use Thereof
App 20180228878 - PIERCE; GLENN ;   et al.
2018-08-16
Targeted coagulation factors and method of using the same
Grant 10,035,840 - Feldman , et al. July 31, 2
2018-07-31
Factor IX Polypeptides and Methods of Use Thereof
App 20180207244 - PIERCE; Glenn ;   et al.
2018-07-26
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
Grant 10,010,622 - Dumont , et al. July 3, 2
2018-07-03
Factor IX polypeptides and methods of use thereof
Grant 9,867,873 - Pierce , et al. January 16, 2
2018-01-16
Methods of Using FIX Polypeptides
App 20180002684 - PIERCE; Glenn ;   et al.
2018-01-04
Factor IX polypeptides and methods of use thereof
Grant 9,675,676 - Pierce , et al. June 13, 2
2017-06-13
Factor IX polypeptides and methods of use thereof
Grant 9,670,475 - Pierce , et al. June 6, 2
2017-06-06
Factor IX polypeptides and methods of use thereof
Grant 9,629,903 - Pierce , et al. April 25, 2
2017-04-25
Factor IX polypeptides and methods of use thereof
Grant 9,623,091 - Pierce , et al. April 18, 2
2017-04-18
Targeted Coagulation Factors And Method Of Using The Same
App 20170051042 - FELDMAN; Richard ;   et al.
2017-02-23
Factor IX Polypeptides and Methods of Use Thereof
App 20160346365 - PIERCE; Glenn ;   et al.
2016-12-01
Factor IX Polypeptides and Methods of Use Thereof
App 20160257943 - Pierce; Glenn ;   et al.
2016-09-08
Factor IX Polypeptides and Methods of Use Thereof
App 20160243206 - PIERCE; Glenn ;   et al.
2016-08-25
Targeted coagulation factors and method of using the same
Grant 9,422,362 - Feldman , et al. August 23, 2
2016-08-23
Factor VIII-Fc Chimeric and Hybrid Polypeptides, and Methods of Use Thereof
App 20160199455 - DUMONT; Jennifer A. ;   et al.
2016-07-14
Factor IX Polypeptides and Methods of Use Thereof
App 20160166657 - PIERCE; Glenn ;   et al.
2016-06-16
Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof
Grant 9,241,978 - Dumont , et al. January 26, 2
2016-01-26
Factor IX polypeptides and methods of use thereof
Grant 9,233,145 - Pierce , et al. January 12, 2
2016-01-12
Methods of Using FIX Polypeptides
App 20150252345 - Pierce; Glenn ;   et al.
2015-09-10
Factor VIII-Fc chimeric and hybrid polypeptides, and methods of use thereof
Grant 9,050,318 - Dumont , et al. June 9, 2
2015-06-09
Assays to Monitor Bleeding Disorders
App 20150079072 - Sommer; Jurg ;   et al.
2015-03-19
Methods Of Reducing Immunogenicity Against Factor Viii In Individuals Undergoing Factor Viii Therapy
App 20140370035 - Jiang; Haiyan ;   et al.
2014-12-18
Factor Viii Chimeric And Hybrid Polypeptides, And Methods Of Use Thereof
App 20140294821 - Dumont; Jennifer A. ;   et al.
2014-10-02
Targeted Coagulation Factors And Method Of Using The Same
App 20140221618 - Feldman; Richard ;   et al.
2014-08-07
Factor VIII-Fc Chimeric and Hybrid Polypeptides, and Methods of Use Thereof
App 20130274194 - Dumont; Jennifer A. ;   et al.
2013-10-17
Factor IX Polypeptides and Methods of Use Thereof
App 20130202595 - Pierce; Glenn ;   et al.
2013-08-08
Traversal Of Nucleic Acid Molecules Through A Fluid Space And Expression In Repair Cells
App 20130190391 - Sosnowski; Barbara A. ;   et al.
2013-07-25
Factor IX Polypeptides and Methods of Use Thereof
App 20130171175 - Pierce; Glenn ;   et al.
2013-07-04
Factor VIII-Fc Chimeric and Hybrid Polypeptides, and Methods of Use Thereof
App 20130108629 - Dumont; Jennifer A. ;   et al.
2013-05-02
FVIII Muteins for Treatment of Von Willebrand Disease
App 20110286988 - Jiang; Haiyan ;   et al.
2011-11-24
Targeted Coagulation Factors and Method of Using the Same
App 20110077202 - Feldman; Richard ;   et al.
2011-03-31
Traversal Of Nucleic Acid Molecules Through A Fluid Space And Expression In Repair Cells
App 20100086598 - Sosnowski; Barbara A. ;   et al.
2010-04-08
Traversal of nucleic acid molecules through a fluid space and expression in repair cells
Grant 7,534,774 - Sosnowski , et al. May 19, 2
2009-05-19
Use of GM-CSF to promote accelerated wound healing
Grant 6,689,351 - Pierce , et al. February 10, 2
2004-02-10
Traversal of nucleic acid molecules through a fluid space and expression in repair cells
App 20030148979 - Sosnowski, Barbara A. ;   et al.
2003-08-07
Methods for halting unwanted cell growth, such as using ligand-directed nucleic acid delivery vehicles
App 20030040496 - Chandler, Lois Ann ;   et al.
2003-02-27
In situ bioreactors and methods of use thereof
App 20010044413 - Pierce, Glenn ;   et al.
2001-11-22
Company Registrations
SEC0001256964PIERCE GLENN

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed